Ultragenyx Pharmaceutical Inc. Insider Trading for October 2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Ultragenyx Pharmaceutical Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Ultragenyx Pharmaceutical Inc. for October 2019.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Oct 16 2019 | RARE | Ultragenyx Pharmac ... | Harris Erik | EVP & Chief Commerc ... | Grant | A | 0.00 | 1,208 | 0 | 14,309 | 13.1 K to 14.3 K (+9.22 %) |
Oct 16 2019 | RARE | Ultragenyx Pharmac ... | Huang Dennis Karl | EVP & Chief Tech Op ... | Grant | A | 0.00 | 1,434 | 0 | 23,579 | 22.1 K to 23.6 K (+6.48 %) |
Oct 16 2019 | RARE | Ultragenyx Pharmac ... | KAKKIS EMIL D | President & CEO | Grant | A | 0.00 | 3,435 | 0 | 475,914 | 472.5 K to 475.9 K (+0.73 %) |
Oct 16 2019 | RARE | Ultragenyx Pharmac ... | Kassberg Thomas Richard | CBO & EVP | Grant | A | 0.00 | 1,434 | 0 | 91,675 | 90.2 K to 91.7 K (+1.59 %) |
Oct 16 2019 | RARE | Ultragenyx Pharmac ... | Parschauer Karah Herdman | EVP and General Cou ... | Grant | A | 0.00 | 1,434 | 0 | 19,084 | 17.7 K to 19.1 K (+8.12 %) |
Oct 16 2019 | RARE | Ultragenyx Pharmac ... | Pinion John Richard | See Remarks | Grant | A | 0.00 | 1,434 | 0 | 39,138 | 37.7 K to 39.1 K (+3.80 %) |
Oct 16 2019 | RARE | Ultragenyx Pharmac ... | Sharp Shalini | CFO & Executive Vic ... | Grant | A | 0.00 | 1,434 | 0 | 100,523 | 99.1 K to 100.5 K (+1.45 %) |
Oct 16 2019 | RARE | Ultragenyx Pharmac ... | Bedrosian Camille L | EVP and Chief Medic ... | Grant | A | 0.00 | 1,437 | 0 | 26,239 | 24.8 K to 26.2 K (+5.79 %) |
Oct 16 2019 | RARE | Ultragenyx Pharmac ... | Huizenga Theodore Alan | SVP, Controller and ... | Grant | A | 0.00 | 800 | 0 | 16,785 | 16 K to 16.8 K (+5.00 %) |
Oct 07 2019 | RARE | Ultragenyx Pharmac ... | Hogenhuis Wladimir | Chief Operating Off ... | Payment of Exercise | F | 44.52 | 1,297 | 57,742 | 18,703 | 20 K to 18.7 K (-6.48 %) |
Oct 07 2019 | RARE | Ultragenyx Pharmac ... | Hogenhuis Wladimir | Chief Operating Off ... | Payment of Exercise | F | 44.52 | 1,297 | 57,742 | 18,703 | 20 K to 18.7 K (-6.48 %) |